Medicines, drugs and medical devices have been the basic need of human population. The pharma industry aims to serve this fundamental need, by the discovery, production and marketing of the drugs that are aimed to prevent the diseases or offer treatment of the diseases to the mankind. Large and small pharma companies are running across the globe to produce drugs and other related pharma products, and lots of them have their stocks listed on the stock exchanges worldwide. This allows for a good opportunity to common investors and traders to benefit from the pharma business. However, one must note that the pharma industry is heavily regulated, and approval or rejection of drugs, patent validity, factory conditions, competitor developments, and similar related parameters decide the fortune of the pharma companies. Among the several pharma companies whose stocks are actively trading on the stock exchanges, which have been the winners in terms of highest returns? This article provides a list of pharma stocks which have generated the highest returns in the year 2021 till date of writing. The list is prepared based on the percentage returns generated by the individual pharma stocks between the end of the previous and Apr 1, 2021, and the top 10 return generating pharma stocks are listed below.
Try our new Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Pharma sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) Immunome, Inc. (IMNM)
There's more... See price performance, YTD-gains, market-cap and other details of all the 94 Pharma stocks with sorting features in a tabular format. Alternatively, one can also explore the List of Top Pharma ETFs.
Here's a look at the basic details and how the above mentioned stocks fared during the period:
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Immunome, Inc.. The Exton, United States-headquartered company Immunome, Inc. (IMNM) is ranked number one among the best performing stocks of Pharma of 2021. The Healthcare sector business falls under the Biotechnology industrial sub-sector. Since the start of the year 2021, the stock price of Immunome, Inc. has changed by 233.99 percent, which is calculated based on the previous year's closing price of $9.68 per share and year-to-date closing price of $32.33 per share as of writing. The market value of the company as indicated by its market-cap changed from $102.04 million to $344.63 million during the same period. Along with Pharma, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Biotech, Healthcare, among other usual products and services.
Ligand Pharmaceuticals Incorporated (Ligand), incorporated on September 28, 1987, is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Ligand Pharma. The California, CA-based Health Care sector company Ligand Pharmaceuticals Incorporated (LGND) holds the number two spot among the best performing stocks of the Pharma sector. Classified as the Major Pharmaceuticals business, the stock price of Ligand Pharma ended the previous year at a price of $99.45 per share while it reached the level of $154.6 apiece as of Apr 1, 2021 translating to a percentage change in stock price of 55.46%. As of writing, the company's market-cap value stands at $2.57 billion. Few leading stock market index includes Ligand Pharma in their constituent list. They include Wilshire 5000 index, Russell 2000 index, and a few other larger indexes which are part of the stock market.
Bausch Health Companies
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Bausch Health Companies. During the given months of the year 2021, Bausch Health Companies Inc. (BHC) was successful in generating YTD returns of 52.45 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the Laval, QC-based Bausch Health Companies closed at a price of $20.8 per share, while it traded at a price of $31.71 per share as of Apr 1, 2021. The company's market cap changed from $7.33 billion to $11.25 billion during the same period YTD. The company is classified under the Health Care industry sector and further specialized as a Healthcare sector business.
Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. It operates thr ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Amneal Pharmaceuticals. The Bridgewater, NJ-based Amneal Pharmaceuticals, Inc. (AMRX) belongs to the Health Care sector and is categorized as a Healthcare company. The stock of Amneal Pharmaceuticals ended the previous year at a price of $4.57 per share. As of Apr 1, 2021, the stock price has reached $6.6 apiece, which indicates a change of 44.42 percent making the company rank among the top performing stocks of the Pharma for the year 2021 till date. At the end of the last year, company's market capitalization stood at $674.66 million. It has now changed to $979.62 million as of writing. Amneal Pharmaceuticals continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators.
Cara Therapeutics, Inc., incorporated on July 2, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Cara Therapeutics. Rank number five in the coveted list is held by Cara Therapeutics, Inc. (CARA) for being among the top performing stocks of 2021. Headquartered in Connecticut, CT, the Health Care sector company is categorized under the industrial sub-sector of Major Pharmaceuticals. Since the start of the year 2021, stock of Cara Therapeutics has so far gained 43.75 percentage, based on the previous year's closing price of $15.13 per share and year-to-date price of $21.75 per share. During the same period, the market capitalization of the company changed from $753.96 million to $1.09 billion. The stock of Cara Therapeutics continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators.
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. The ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Atea Pharmaceuticals, Inc.. At number six in the list of top stocks stands Atea Pharmaceuticals, Inc. (AVIR), which saw a change in its stock price from the level of $41.78 apiece during previous year December end to the price of $57.81 per share as of Apr 1, 2021. It translates to a change of 38.37 percentage. The Boston, United States-headquartered Healthcare sector company also saw its market value change from $3.45 billion to $4.78 billion.
Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., incorporated on July 21, 2006, is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Catalyst Pharma. Catalyst Pharmaceuticals, Inc. (CPRX) has moved by 35.03 percentage over the given period of 2021-YTD, helping it gain a place at number seven among the top performing stocks. The Health Care sector company managed to achieve the feat as its stock price changed from $3.34 apiece to the price of $4.51 per share between the end of December of the previous year and Apr 1, 2021. The smart run of the Florida, FL-based Major Pharmaceuticals sector company lead to a handsome gain in its marketcap which changed from $346.18 million to $468.25 million over the same duration. Catalyst Pharma is a key member of many popular stock market indexes. They include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators.
Aerie Pharmaceuticals, Inc., incorporated on June 22, 2005, is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Aerie Pharma. Based on the market-cap change from $632.47 million to $833.72 million during the given months of the year 2021 and the share price change from $13.51 per share to a price of $17.77 per share as of Apr 1, 2021, Aerie Pharmaceuticals, Inc. (AERI) was successful in generating YTD returns of 31.53 percentage. Standing at the number eight rank in the top performing list of Pharma stocks, the New Jersey, NJ-based Aerie Pharma is categorized as the Biotech Biological Products sub-sector business which falls under the larger Health Care sector. It is also a part of few famous stock indexes that are used to track the overall performance of the stock market. They include Wilshire 5000 index, Russell 2000 index, and a few more broader-level indexes that are actively tracked in the market.
Phibro Animal Health
Phibro Animal Health Corporation (Phibro), incorporated on January 27, 2014, is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Phibro Animal Health. Phibro Animal Health (PAHC) generated percentage returns of 28.73 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $19.42 per share from the previous year-end to the price of $25 per share as of Apr 1, 2021. The company's value, as indicated by the market-cap figure, changed from $785.61 million to $1.01 billion during the same period. The company is categorized as a Health Care speciality business with further classification in the Major Pharmaceuticals sub-category. Based in New Jersey, NJ, the YTD performance of the Pharma sector also fared better than that of the returns generated by some of the closley tracked stock market indexes. The company is a part of Wilshire 5000 index, Russell 2000 index, and a few other wider multi-cap stock market indexes.
Omeros Corporation, incorporated on June 16, 1994, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market, as well as orphan ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Omeros. The number ten spot in the list of top performing stocks of the Pharma sector is taken by Omeros Corporation (OMER). The company's stock price changed from $14.28 per share at the end of December of the previous year to the price of $18.19 per share as of writing. Overall, the stock managed to realized price change of 27.38 percent during the given time period. The corresponding change in the market capitalization value of the Washington, WA-based Health Care sector company was from $880.7 million to $1.13 billion. Being ranked in the top 10 best performing stocks of the Pharma sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Wilshire 5000 index, Russell 2000 index, and a handful of other multi-capitalization indexes.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.